On October 






SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

 








Theseus Pharmaceuticals, Inc.






By:


 


/s/ Bradford D. Dahms




 


Name: Bradford D. Dahms




 


Title: Chief Financial Officer


Date: October 27, 2021




makes a similar move, sign up!

Auto Refresh

Feedback